A Phase II Trial of Adjuvant Capecitabine/Gemcitabine Chemotherapy Followed By Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma (EHCC).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Capecitabine (Primary) ; Gemcitabine (Primary)
- Indications Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- 14 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 02 Jan 2013 Planned end date changed from 1 Dec 2014 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 03 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.